首页> 美国卫生研究院文献>Adolescent Health Medicine and Therapeutics >Natural History and Disease Burden of Neurofibromatosis Type 1 with Plexiform Neurofibromas: A Systematic Literature Review
【2h】

Natural History and Disease Burden of Neurofibromatosis Type 1 with Plexiform Neurofibromas: A Systematic Literature Review

机译:神经纤维瘤病型的自然历史和疾病负担具有丛状神经纤维瘤:系统文献综述

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Neurofibromatosis type 1 (NF1) is an incurable genetic condition that frequently includes the development of plexiform neurofibromas (PNs) in patients. A systematic literature review was conducted to identify data on the natural history, disease burden, and treatment patterns among patients diagnosed with NF1 and PN, as well as to identify evidence gaps in these areas. MEDLINE and MEDLINE In-Process, Embase, and Cochrane Library Searches were searched using predefined terms. Potential references underwent two phases of screening by two independent researchers. A total of 39 references focusing on populations of patients with both NF1 and PN were included in this review. The wide range of PN-related complications creates a substantial quality-of-life (QOL) burden for patients, including pain, social functioning, physical function impact, stigma, and emotional distress. The severe burden of NF1 with PN on the QOL of patients demonstrates the high unmet need for an effective treatment option that can reduce tumor burden and improve QOL. The heterogeneity of measurement tools used to evaluate QOL and the gap in data evaluating the health economic burden of PN should be the focus of future research.
机译:神经纤维瘤病1(NF1)是一种可治区遗传条件,通常包括在患者中发育丛状神经纤维瘤(PNS)。进行了系统文献综述,以确定患有NF1和PN患者的自然历史,疾病负担和治疗模式的数据,以及识别这些领域的证据差距。使用预定义的术语搜索Medline和Medline In-Process,Embase和Cochrane库搜索。潜在的参考文献经过两个独立的研究人员筛选两阶段。本次审查中,共注明患有NF1和PN患者群体的39个参考文献。广泛的PN相关并发症为患者提供了大量的寿命(QOL)负担,包括疼痛,社会功能,身体功能影响,耻辱和情绪困扰。 NF1对PN的严重负担患者QoL QoL表明了对有效治疗选择的高未满足需要,可降低肿瘤负担和改善QOL。用于评估QOL的测量工具的异质性和评估PN健康经济负担的数据差距应该是未来研究的重点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号